prednisolone has been researched along with Neuronal Ceroid-Lipofuscinoses in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Neuronal Ceroid-Lipofuscinoses: A group of severe neurodegenerative diseases characterized by intracellular accumulation of autofluorescent wax-like lipid materials (CEROID; LIPOFUSCIN) in neurons. There are several subtypes based on mutations of the various genes, time of disease onset, and severity of the neurological defects such as progressive DEMENTIA; SEIZURES; and visual failure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aberg, L | 1 |
| Talling, M | 1 |
| Härkönen, T | 1 |
| Lönnqvist, T | 1 |
| Knip, M | 1 |
| Alen, R | 1 |
| Rantala, H | 1 |
| Tyynelä, J | 1 |
1 trial available for prednisolone and Neuronal Ceroid-Lipofuscinoses
| Article | Year |
|---|---|
Intermittent prednisolone and autoantibodies to GAD65 in juvenile neuronal ceroid lipofuscinosis.
Topics: Adolescent; Age Factors; Autoantibodies; Biomarkers; Brain; Child; Dose-Response Relationship, Drug; | 2008 |